Ardelyx | search
Click here to view Ardelyx news from 60+ newspapers.
Bookmark or Share- Press Releases | ArdelyxArdelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community. Oct 21, 2024. Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community. Oct 17, 2024.
- Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and ...Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update. March 2, 2023. PDF Version. Continued successful launch of IBSRELA, ending FY 2022 with $15.6 million in net product sales. Resubmission of XPHOZAH New Drug Application expected in early Q2 2023.
- Investors & Media | ArdelyxThe Investor Relations website contains information about Ardelyx's business for stockholders, potential investors, and financial analysts.
- Clinical Trials - ArdelyxClinical trials are crucial for advancing medical knowledge and improving patient care by providing evidence-based insights. They involve collaboration between researchers, healthcare professionals, and willing participants, playing a pivotal role in shaping the future of medicine.
- Open Positions - ArdelyxAny candidate selected for consideration for a role will be contacted directly by a member of the Ardelyx Human Resources Team via email.
More
